Lung Cancer Clinical Trials in Hackensack, New Jersey
5 studies are recruiting for lung cancer in Hackensack, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey
- Locations
- 65 in total
- Run by
- Bristol-Myers Squibb
-
Leveraging the Emergency Department (LEAD) Study
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligi…
- Stage
- Not phased
- Ages
- 50 to 80
- Site
- Hackensack University Medical Center, Hackensack, New Jersey
- Locations
- 10 in total
- Run by
- Hackensack Meridian Health
-
Support for Cancer Patients Awaiting News
This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the inter…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Amanda Khoudary, Hackensack, New Jersey
- Run by
- Hackensack Meridian Health
-
Empathic Communication Skills (ECS) Training
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma …
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- Hackensack Meridian Health (Data collection only), Hackensack, New Jersey
- Locations
- 12 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hackensack University Medical Center, Hackensack, New Jersey
- Locations
- 21 in total
- Run by
- Clasp Therapeutics, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.